Last reviewed · How we verify
ketamine plus magnesium sulfate plus general anesthesia — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
ketamine plus magnesium sulfate plus general anesthesia (ketamine plus magnesium sulfate plus general anesthesia) — University of Sao Paulo General Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ketamine plus magnesium sulfate plus general anesthesia TARGET | ketamine plus magnesium sulfate plus general anesthesia | University of Sao Paulo General Hospital | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ketamine plus magnesium sulfate plus general anesthesia CI watch — RSS
- ketamine plus magnesium sulfate plus general anesthesia CI watch — Atom
- ketamine plus magnesium sulfate plus general anesthesia CI watch — JSON
- ketamine plus magnesium sulfate plus general anesthesia alone — RSS
Cite this brief
Drug Landscape (2026). ketamine plus magnesium sulfate plus general anesthesia — Competitive Intelligence Brief. https://druglandscape.com/ci/ketamine-plus-magnesium-sulfate-plus-general-anesthesia. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab